Search by Drug Name or NDC
NDC 00574-0621-05 Podofilox 5 mg/g Details
Podofilox 5 mg/g
Podofilox is a TOPICAL GEL in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Padagis US LLC. The primary component is PODOFILOX.
Product Information
| NDC | 00574-0621 |
|---|---|
| Product ID | 0574-0621_d2e70c5e-d4a9-4295-9eff-517ffb974e61 |
| Associated GPIs | |
| GCN Sequence Number | 030857 |
| GCN Sequence Number Description | podofilox GEL (GRAM) 0.5 % TOPICAL |
| HIC3 | L5A |
| HIC3 Description | KERATOLYTICS |
| GCN | 23450 |
| HICL Sequence Number | 006081 |
| HICL Sequence Number Description | PODOFILOX |
| Brand/Generic | Generic |
| Proprietary Name | Podofilox |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Podofilox |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | GEL |
| Route | TOPICAL |
| Active Ingredient Strength | 5 |
| Active Ingredient Units | mg/g |
| Substance Name | PODOFILOX |
| Labeler Name | Padagis US LLC |
| Pharmaceutical Class | Decreased Mitosis [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA211871 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00574-0621-05 (00574062105)
| NDC Package Code | 0574-0621-05 |
|---|---|
| Billing NDC | 00574062105 |
| Package | 3.5 g in 1 TUBE, WITH APPLICATOR (0574-0621-05) |
| Marketing Start Date | 2023-12-13 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |